Furthermore, Palumbo et al. showed that rhEpo fails to modulate pemetrexed or cisplatin sensitivity of EpoR expressing mesothelioma cell lines, despite phosphorylating Akt [29]. The gene discussed is AKT1; the disease is mesothelioma.